Literature DB >> 12077734

Hepatic gluconeogenic capacity from various precursors in young versus old rats.

Ken D Sumida1, Suzanne C Crandall, Puja L Chadha, Tauseef Qureshi.   

Abstract

Hepatic gluconeogenic capacity was studied in young (4 months of age) and old (24 months of age) male Fischer 344 rats fasted for 24 hours using the isolated hepatocyte technique. Following the isolation of liver cells, the following precursors were added to the cell suspensions and incubated for 30 minutes: lactate (5 mmol/L), pyruvate (5 mmol/L), alanine (5 mmol/L), glutamine (5 mmol/L), oxaloacetate (5 mmol/L), glycerol (5 mmol/L), dihydroxyacetone (10 mmol/L), fructose (10 mmol/L), or saline (no precursor addition). To confirm that glucose production reflects gluconeogenic capacity, there was significant depletion of hepatic glycogen after the 24-hour fast and minimal alterations in glycogen content once substrates were added. Adjusting the gluconeogenic rates to reflect 100% cell viability resulted in no difference between young and old animals for any substrate used with the sole exception of fructose. The hepatic glucose production from fructose was 34% greater for young versus old animals. The results suggest that following a period of starvation the basal glucose production rates from hepatocytes, incubated with precursors entering the gluconeogenic pathway prior to fructose-6-phosphate, are equivalent in young and old rats. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077734     DOI: 10.1053/meta.2002.33342

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  Proliferation of sphere-forming hepatocellular carcinoma cells is suppressed in a medium without glucose and arginine, but with galactose and ornithine.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Oncol Lett       Date:  2017-01-02       Impact factor: 2.967

2.  Cell death in a co-culture of hepatocellular carcinoma cells and human umbilical vascular endothelial cells in a medium lacking glucose and arginine.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Oncol Lett       Date:  2016-11-30       Impact factor: 2.967

3.  Proliferation and motility of hepatocellular, pancreatic and gastric cancer cells grown in a medium without glucose and arginine, but with galactose and ornithine.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Oncol Lett       Date:  2017-01-04       Impact factor: 2.967

4.  Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  World J Methodol       Date:  2015-09-26

5.  Antiproliferative effect of dihydroxyacetone on Trypanosoma brucei bloodstream forms: cell cycle progression, subcellular alterations, and cell death.

Authors:  Néstor L Uzcátegui; Didac Carmona-Gutiérrez; Viola Denninger; Caroline Schoenfeld; Florian Lang; Katherine Figarella; Michael Duszenko
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

6.  Restoration of energy homeostasis by SIRT6 extends healthy lifespan.

Authors:  A Roichman; S Elhanati; M A Aon; I Abramovich; A Di Francesco; Y Shahar; M Y Avivi; M Shurgi; A Rubinstein; Y Wiesner; A Shuchami; Z Petrover; I Lebenthal-Loinger; O Yaron; A Lyashkov; C Ubaida-Mohien; Y Kanfi; B Lerrer; P J Fernández-Marcos; M Serrano; E Gottlieb; R de Cabo; H Y Cohen
Journal:  Nat Commun       Date:  2021-05-28       Impact factor: 14.919

7.  Survival of primary human hepatocytes and death of induced pluripotent stem cells in media lacking glucose and arginine.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi; Takanobu Yoshida
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.